| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.052 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.048 | 0.8 |